{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:41:56Z","timestamp":1761709316038,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40261-017-0529-9","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T06:14:03Z","timestamp":1492841643000},"page":"755-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prescription Appropriateness of Cyproterone Acetate\/Ethinylestradiol in Primary Care: A Population-Based Study in Italy"],"prefix":"10.1007","volume":"37","author":[{"given":"Francesco","family":"Lapi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino A.","family":"Vena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"key":"529_CR1","first-page":"392","volume":"27","author":"S Aydinlik","year":"1990","unstructured":"Aydinlik S, Kaufmann JK, Lachnit-Fixson U, et al. Long-term therapy of signs of androgenisation with a low-dosed antiandrogen\u2013oestrogen combination. Clin Trials J. 1990;27:392\u2013402.","journal-title":"Clin Trials J."},{"key":"529_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humrep\/dem379","volume":"23","author":"S Franks","year":"2008","unstructured":"Franks S, Layton A, Glasier A. Cyproterone acetate\/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy. Hum Reprod. 2008;23:231\u20132.","journal-title":"Hum Reprod"},{"key":"529_CR3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humrep\/deg120","volume":"18","author":"HE Seaman","year":"2003","unstructured":"Seaman HE, de Vries CS, Farmer RDT. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case\u2013control study. Hum Reprod. 2003;18:522\u20136.","journal-title":"Hum Reprod"},{"key":"529_CR4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","volume":"366","author":"\u00d8 Lidegaard","year":"2012","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257\u201366.","journal-title":"N Engl J Med"},{"key":"529_CR5","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","volume":"347","author":"BH Stegeman","year":"2013","unstructured":"Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:f5298.","journal-title":"BMJ"},{"key":"529_CR6","doi-asserted-by":"crossref","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;(3):CD010813.","DOI":"10.1002\/14651858.CD010813.pub2"},{"key":"529_CR7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jth.12622","volume":"12","author":"A Kant","year":"2014","unstructured":"Kant A, van Puijenbroek E, van Hunsel F. Reflections after the Diane affair. J Thromb Haemost. 2014;12:1385\u20137.","journal-title":"J Thromb Haemost"},{"key":"529_CR8","unstructured":"European Medicines Agency. Assessment report cyproterone acetate\/ethinylestradiol (2\u00a0mg\/0.035\u00a0mg) containing medicinal products. Procedure number: EMEA\/H\/A-107i\/1357 (24 May 2013). \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/cyproterone_ethinylestradiol_107i\/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee\/WC500144130.pdf\n                        \n                    . Accessed Jan 2017."},{"key":"529_CR9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/pubmed\/fdg060","volume":"25","author":"C Cricelli","year":"2003","unstructured":"Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med. 2003;25:254\u20137.","journal-title":"J Public Health Med"},{"key":"529_CR10","first-page":"311","volume":"6","author":"A Filippi","year":"2005","unstructured":"Filippi A, Vanuzzo D, Bignamini AA, Mazzaglia G, Cricelli C, Catapano AL. The database of Italian general practitioners allows a reliable determination of the prevalence of myocardial infarction. Ital Heart J. 2005;6:311\u20134.","journal-title":"Ital Heart J"},{"key":"529_CR11","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598\u2013605.","journal-title":"Circulation"},{"key":"529_CR12","first-page":"593","volume":"20","author":"GA Vena","year":"2010","unstructured":"Vena GA, Altomare G, Ayala F, et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010;20:593\u20138.","journal-title":"Eur J Dermatol."},{"key":"529_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/13625187.2015.1102220","volume":"21","author":"ID Bezemer","year":"2016","unstructured":"Bezemer ID, Verhamme KM, Gini R, et al. Use of oral contraceptives in three European countries: a population-based multi-database study. Eur J Contracept Reprod Health Care. 2016;21:81\u20137.","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"529_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jfprhc-2015-101202","volume":"42","author":"L Cea-Soriano","year":"2016","unstructured":"Cea-Soriano L, Wallander M-A, Garc\u00eda Rodr\u00edguez LA. Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK. J Fam Plan Reprod Health. 2016;42:247\u201354.","journal-title":"J Fam Plan Reprod Health"},{"key":"529_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2016.10.003","volume":"95","author":"L Cea Soriano","year":"2017","unstructured":"Cea Soriano L, Asiimwe A, Garc\u00eda Rodriguez LA. Prescribing of cyproteroneacetate\/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. Contraception. 2017;95:299\u2013305.","journal-title":"Contraception."},{"key":"529_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13625187.2016.1241991","volume":"22","author":"C Barnett","year":"2017","unstructured":"Barnett C, Hagemann C, Dinger J, Do Minh T, Heinemann K. Fertility and combined oral contraceptives\u2014unintended pregnancies and planned pregnancies following oral contraceptive use\u2014results from the INAS-SCORE study. Eur J Contracept Reprod Health Care. 2017;22:17\u201323.","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"529_CR17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","volume":"89","author":"J Dinger","year":"2014","unstructured":"Dinger J, Bardenheuer K, Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception. 2014;89:253\u201363.","journal-title":"Contraception."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0529-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T06:09:01Z","timestamp":1499926141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0529-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0529-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2017,4,22]]}}}